Want to join the conversation?
Provider of IT technology $CDK said that its BoD as authorized the acceleration $1Bil return of capital plan such that the remaining $710MM that has not yet been returned to shareholders will be returned. This will be done through a combination of share repurchases and quarterly dividends, by the end of calendar year 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.